SANTA MONICA, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (Nasdaq: OPNT), a company advancing medicines to better treat addictions and drug overdose, today announced that members of the company’s senior management team will participate in the 12th Jefferies London Healthcare Conference virtually on Thursday, November 18 and Friday, November 19. Management will participate in investor 1x1 meetings on both days. A webcast of the event will be available from November 18, 2021, 8:00 AM GMT / 3:00 AM ET on the Opiant website.
About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com.
For Media and Investor Inquiries:
Ben Atkins, Opiant
Source: Opiant Pharmaceuticals, Inc.